Importantly, a short interval treatment of CpG/aOX40 significantly reduced the fraction of immunosuppressive Tregs within mouse MYC-driven TNBC tumors and increased both numbers and functionality of tumor infiltrating cytotoxic CD8 + T cells. This evidence concerns the gene CD8A and neoplasm.